OptiBiotix shares jump amid media interest generated by potential US commercial partner
OptiBiotix said it can confirm it is in discussions with Seed Heath to agree commercial terms for the use of its LP-LDL strain in Seed's products in preparation for a May launch in the US
More From BioPortfolio on "OptiBiotix shares jump amid media interest generated by potential US commercial partner"